Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Perceived Impact of a Self-Management Program for Fatigue in Multiple Sclerosis: A Qualitative Study.
Alemtuzumab for multiple sclerosis.
[Multiple sclerosis and physical activity : An historical perspective.]
Inner Nuclear Layer Thickening Is Inversley Proportional to Retinal Ganglion Cell Loss in Optic Neuritis.
A case of neuromyelitis optica spectrum disorder associated with a limited cutaneous systemic sclerosis and Sjögren syndrome.
Review of daclizumab and its therapeutic potential in the treatment of relapsing-remitting multiple sclerosis.
Autophagy-related gene16L2, a potential serum biomarker of multiple sclerosis evaluated by bead-based proteomic technology.
An unusual case of 'itchy paralysis': neuromyelitis optica presenting with severe neuropathic itch.
Genetic disruption of Pten in a novel mouse model of tomaculous neuropathy.
Role of phospholipase A(2)s and lipid mediators in secondary damage after spinal cord injury.
Brachial plexus atrophy in chronic inflammatory demyelinating polyradiculoneuropathy.
Preliminary study on patients located at the Kashani/Isfahan Hospital with multiple sclerosis between the years 2011 and 2013.
Ultraviolet radiation, vitamin D and multiple sclerosis.
Relapse May Serve as a Mediator Variable in Longitudinal Outcomes in Multiple Sclerosis.
PAMP-DAMPs interactions mediates development and progression of multiple sclerosis.
Multiple sclerosis - a dynamic field with a need for excellent education.
Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling.
Can people with multiple sclerosis actually understand what they read in the Internet age?
Deciphering Depressive Mood in Relapsing-Remitting and Progressive Multiple Sclerosis and Its Consequence on Quality of Life.
Quetiapine Inhibits Microglial Activation by Neutralizing Abnormal STIM1-Mediated Intercellular Calcium Homeostasis and Promotes Myelin Repair in a Cuprizone-Induced Mouse Model of Demyelination.
Functional adaptation of presynaptic chemokine receptors in EAE mouse central nervous system.
The melanocortin ACTH 1-39 promotes protection of oligodendrocytes by astroglia.
Longitudinal T cell-derived IFN-γ/IL-17 balances do not correlate with the disease course in two mouse models of experimental autoimmune encephalomyelitis.
Chronic inflammatory demyelinating polyneuropathy with papillodema and response to immunoglobulins.
Fatigue in Multiple Sclerosis Compared to Stroke.
Pages
« first
‹ previous
…
678
679
680
681
682
683
684
685
686
…
next ›
last »